Jonas Oldgren
Uppsala University Hospital
Troponin IInternal medicineSurgeryCardiologyIntensive care medicineWarfarinHeparinAcute coronary syndromeAnticoagulantCoronary artery diseaseChest painDabigatranAtrial fibrillationInogatranPercutaneous coronary interventionIn patientTroponinAnesthesiaMyocardial infarctionStrokeMedicine
37Publications
14H-index
804Citations
Publications 38
Newest
#1Julia AulinH-Index: 4
#2Ziad HijaziH-Index: 25
Last. Lars WallentinH-Index: 150
view all 14 authors...
Biomarkers predict risk for heart failure in patients with atrial fibrillation: Insights from the ARISTOTLE trial
#1Alexander P. BenzH-Index: 3
#2Jeff S. HealeyH-Index: 2
Last. Stuart J. ConnollyH-Index: 140
view all 10 authors...
1 CitationsSource
#1Birgitta JönelidH-Index: 3
#2Bertil LindahlH-Index: 83
Last. Christina ChristerssonH-Index: 14
view all 7 authors...
AbstractBackground: Few studies have investigated biomarkers and their association to cardiovascular (CV) outcomes in patients with myocardial infarction (MI) and peripheral artery disease (PAD). T ...
#1Jonas Oldgren (Uppsala University Hospital)H-Index: 14
Forstahandsvalet som strokeprevention vid formaksflimmer : Randomiserade studier med >70 000 patienter har visat pa fordelarna med NOAK
#1David Eccleston (University of Melbourne)H-Index: 13
#2J. M. ten BergH-Index: 18
Last. Jonas OldgrenH-Index: 14
view all 12 authors...
Source
#1Harsh Golwala (Brigham and Women's Hospital)H-Index: 16
#2Christopher P. Cannon (Brigham and Women's Hospital)H-Index: 168
Last. Deepak L. Bhatt (Brigham and Women's Hospital)H-Index: 167
view all 12 authors...
Aims: Of patients with atrial fibrillation (AF), approximately 10% undergo percutaneous coronary intervention (PCI). We studied the safety and efficacy of dual vs. triple antithrombotic therapy (DA ...
101 CitationsSource
#1Ziad HijaziH-Index: 25
#2Jonas OldgrenH-Index: 14
Last. Lars WallentinH-Index: 20
view all 13 authors...
3 CitationsSource
#1Gorav BatraH-Index: 5
#2Anders AhlssonH-Index: 19
Last. Jonas OldgrenH-Index: 14
view all 6 authors...
1 CitationsSource
#1Christopher P. Cannon (Harvard University)H-Index: 168
#2Savion Gropper (Boehringer Ingelheim)H-Index: 7
Last. Stefan H. Hohnloser (Goethe University Frankfurt)H-Index: 89
view all 16 authors...
Antithrombotic management of patients with atrial fibrillation (AF) undergoing coronary stenting is complicated by the need for anticoagulant therapy for stroke prevention and dual antiplatelet the ...
54 CitationsSource
#1Andreas Terént (Uppsala University)H-Index: 57
#2Signild ÅsbergH-Index: 13
Last. Bo Norrving (Lund University)H-Index: 96
view all 5 authors...
Early or delayed onset of oral anticoagulant therapy in patients with acute ischemic stroke with atrial fibrillation is an unsolved issue. Retrospectively, 294 patient records at two hospitals were scrutinized according to a protocol consisting of 20 items regarding choice of therapy (warfarin or NOAC), time for onset of therapy, CT findings of bleeding, capacity to swallow, and occurrence of clinical deterioration during the acute phase. Out of 249 patients who survived the acute phase, 116 (47...
1 Citations